Lantheus Holdings (LNTH) Other Non-Current Assets (2014 - 2025)
Lantheus Holdings (LNTH) reported Other Non-Current Assets of $80.7 million for Q4 2025, up 890.21% year-over-year from $8.2 million in Q4 2024, and up 50.3% quarter-over-quarter from $53.7 million in Q3 2025.
Lantheus Holdings (LNTH) Other Non-Current Assets (2014 - 2025) Analysis & Trends
Lantheus Holdings (LNTH) has 12 years of Other Non-Current Assets data on file, last reported at $80.7 million in Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $80.7 million, up 890.21% year-over-year; the trailing twelve-month figure through Dec 2025 was $80.7 million (up 890.21% YoY), and the FY2025 annual result was $80.7 million, up 890.21% from the prior year.
- Other Non-Current Assets improved to $80.7 million in Q4 2025 per LNTH's latest filing, from $53.7 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $80.7 million in Q4 2025 and troughed at $7.2 million in Q1 2024.
- A 5-year average of $38.3 million and a median of $39.1 million in 2023 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets slumped 87.26% in 2024, then surged 890.21% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $38.8 million in 2021, then dropped by 11.36% to $34.4 million in 2022, then soared by 60.85% to $55.3 million in 2023, then sank by 85.24% to $8.2 million in 2024, then surged by 890.21% to $80.7 million in 2025.
- Business Quant data shows LNTH's Other Non-Current Assets at $80.7 million in Q4 2025, $53.7 million in Q3 2025, and $36.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.79 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 351.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 233.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 73.60 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 295.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.36 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 47.63 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 3.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 80.74 Mn |
| Sep 30, 2025 | 53.72 Mn |
| Jun 30, 2025 | 36.39 Mn |
| Mar 31, 2025 | 36.47 Mn |
| Dec 31, 2024 | 8.15 Mn |
| Sep 30, 2024 | 7.16 Mn |
| Jun 30, 2024 | 7.16 Mn |
| Mar 31, 2024 | 7.16 Mn |
| Dec 31, 2023 | 55.26 Mn |
| Sep 30, 2023 | 56.21 Mn |
| Jun 30, 2023 | 39.13 Mn |
| Mar 31, 2023 | 33.61 Mn |
| Dec 31, 2022 | 34.36 Mn |
| Sep 30, 2022 | 41.63 Mn |
| Jun 30, 2022 | 42.16 Mn |
| Mar 31, 2022 | 42.20 Mn |
| Dec 31, 2021 | 38.76 Mn |
| Sep 30, 2021 | 45.29 Mn |
| Mar 31, 2021 | 61.36 Mn |
| Dec 31, 2020 | 60.63 Mn |